These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6757942)

  • 21. Relapse of multiple sclerosis following acute allergic reactions to plasma during plasmapheresis.
    Wirguin I; Shinar E; Abramsky O
    J Neurol; 1989 Jan; 236(1):62-3. PubMed ID: 2915232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scientific overview of systemic lupus erythematosus (SLE).
    Jasin HE
    Prog Clin Biol Res; 1982; 106():65-80. PubMed ID: 6757954
    [No Abstract]   [Full Text] [Related]  

  • 23. Multiple sclerosis: human model for EAE?
    Hohlfeld R
    Eur J Immunol; 2009 Aug; 39(8):2036-9. PubMed ID: 19672899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An autopsy case of acute multiple sclerosis (Marburg's type) during pregnancy.
    Letournel F; Cassereau J; Scherer-Gagou C; Bernard I; Mercat A; Gray F; Tanguy JY; Richard-Crémieux I; Jeanfaivre T; Barthelaix A; Dubas F
    Clin Neurol Neurosurg; 2008 May; 110(5):514-7. PubMed ID: 18342435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pathogenesis and basis for treatment in multiple sclerosis.
    Compston A
    Clin Neurol Neurosurg; 2004 Jun; 106(3):246-8. PubMed ID: 15177777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic plasmapheresis in multiple sclerosis (preliminary report)].
    Bokonjić R; Kantardzić D; Haracić M
    Neurologija; 1984; 32(1-2):3-11. PubMed ID: 6472573
    [No Abstract]   [Full Text] [Related]  

  • 27. [Plasmapheresis in acute phase of multiple sclerosis].
    Matsuo H
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():191-5. PubMed ID: 26480699
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasmapheresis in multiple sclerosis.
    McLeod BC
    J Clin Apher; 2003; 18(2):72-4. PubMed ID: 12874820
    [No Abstract]   [Full Text] [Related]  

  • 29. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
    Hermans G; Denzer U; Lohse A; Raus J; Stinissen P
    J Autoimmun; 1999 Sep; 13(2):233-46. PubMed ID: 10479392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards individualised multiple-sclerosis therapy.
    Gold R; Hartung HP
    Lancet Neurol; 2005 Nov; 4(11):693-4. PubMed ID: 16239174
    [No Abstract]   [Full Text] [Related]  

  • 31. Cellular immunity in multiple sclerosis.
    Rysková O; Vejbora O; Chromová L; Pekárek J; Chmelar V; Zaydlar K
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1981; 24(1):85-91. PubMed ID: 6975970
    [No Abstract]   [Full Text] [Related]  

  • 32. Disease modifying therapies in multiple sclerosis.
    Khatri BO; McQuillen MP
    Neurology; 2002 Aug; 59(3):472; author reply 472-3. PubMed ID: 12184316
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapeutic applications of hemapheresis].
    Huestis DW; Pineda AA
    Sangre (Barc); 1982; 27(6):1059-72. PubMed ID: 6764036
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of lymphocytapheresis on multiple sclerosis].
    Munakata R; Utsugisawa K; Nagane Y; Ukitsu M; Tohgi H
    No To Shinkei; 1999 Mar; 51(3):235-9. PubMed ID: 10226287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple sclerosis.
    Hafler DA; Slavik JM; Anderson DE; O'Connor KC; De Jager P; Baecher-Allan C
    Immunol Rev; 2005 Apr; 204():208-31. PubMed ID: 15790361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Multiple sclerosis: acute state or malignant course?].
    Shutov AA; Baĭdina TV; Zotova NV
    Klin Med (Mosk); 1993; 71(2):36-8. PubMed ID: 8046921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of peptides to multiple sclerosis research.
    Alcaro MC; Papini AM
    Biopolymers; 2006; 84(4):349-67. PubMed ID: 16518843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pathology of multiple sclerosis and its evolution.
    Lassmann H
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1635-40. PubMed ID: 10603616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the immunosuppressive effects of cyclophosphamide in patients with multiple sclerosis.
    ten Berge RJ; van Walbeek HK; Schellekens PT
    Clin Exp Immunol; 1982 Dec; 50(3):495-502. PubMed ID: 7165996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological questions on hematopoietic stem cell transplantation for multiple sclerosis.
    Muraro PA; Martin R
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S41-4. PubMed ID: 12931240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.